Consistently, the combination of anti-CCDC25 neutralizing mAb and chemotherapy significantly reduced tumor growth (Figure 6P) and lung and liver metastasis (Figure 6, Q and R), while NET levels were comparable in the presence or absence of anti-CCDC25 neutralizing antibody (Supplemental Figure 10, P and Q). The gene discussed is CCDC25; the disease is neoplasm.